Title: Activated CD4 T Cells Spontaneously Producing HIV1 in Breast Milk from Women Treated with Antiretrov
1Activated CD4 T Cells Spontaneously Producing
HIV-1 in Breast Milk from Women Treated with
Antiretroviral Drugs
- Diane Valea, Edouard Tuaillon, Yassine Al Tabaa,
François Rouet , Pierre-Alain Rubbo, Nicolas
Meda, Vincent Foulongne, Karine Bollore,
Jean-Pierre Vendrell and Philippe Van de Perre
-Centre Muraz, Bobo-Dioulasso, Burkina
Faso -University Montpellier 1, EA 4205, France
2Background (1)
- Mechanisms of breast milk transmission of HIV-1
remain poorly understood - In breast milk, HIV-1 may be present as three
different forms - Cell-free virus (CFV) measured as HIV-1 RNA in
lactoserum, - Cell-associated virus (CAV) measured as HIV-1 RNA
released in supernatants by activated cells, - Integrated provirus measured as HIV-1 DNA.
3Background (2)
- Some babies breastfed by HIV-1 infected mothers
taking HAART get infected despite HIV RNA being
undetectable in their mothers plasma and breast
milk (Manigart O et al, J Infect Dis 2004 Thomas
T et al, CROI 2008, abstr. 45 aLB) - In vitro, HIV-1 infectivity is known to be 100 to
1000 times higher in CAV than in CFV stocks
(Dimotrov DS et al, J Virol 1993) -
4Objective
- To study activated CD4T cells producing
spontaneously HIV-1 possibly responsible for
HIV-1 postnatal transmission through
breastfeeding - Sample collection from HIV-1 infected lactating
women receiving short regimen PMTCT prophylaxis
or HAART, - Characterization/enumeration of freshly purified
CD4 T-cells using an ELISPOT assay, - HIV-1 RNA quantification in supernatants after
overnight cell-culture.
5Methods (1) Study population and sample
collection
- 15 HIV-1 infected lactating women (9 on short
perinatal regimen, 6 on HAART), - 70 ml of milk and 20 ml of blood for each woman,
- Mean duration of lactation, 42.2 days (range 9-91
days). -
6Methods (2) Characterization of CD4T cells in
breast milk and blood
A
Breast milk cells plus red blood cells from
healthy control
Spin
Enriched CD4 T cells
Ficoll-
-
hypaque
Red blood cells and
Rosetted (unwanted cells)
Characterization of CD4T cells by flow cytometry
B
Day 0
HIV-1 RNA quantification in supernatants by real
time RT-PCR
Quiescent CD4 T cells
Day 1
Enumeration of the HIV-1-Ag -SCs by ELISPOT
assay
Day 1
Quiescent spontaneous activated CD4 T cells
HIV-1
antigens HIV-1 RNA
7Results (1) cells surface markers expression on
breast milk and blood T lymphocytes
amean with range in parenthesis bNS,not
significantly
8Results (2) Detection of ex-vivo CD4T
lymphocytes secreting spontaneously HIV-1 Ag in
milk and blood
N7
N8
N7
N8
9Results (3) Quantification of Cell-associated-HIV
-1 RNA in culture supernatants
N7
N8
N7
N8
10Sammury (1)
- Most of breast milk CD4 T cells expressed low
level of surface-CD45RA, high levels of HLA-DR
and CD38 markers, characterizing spontaneously
activated memory cells. - Our data
- are consistent with the physiological role of
breast milk as a source of immune active cells, - suggest a minimal blood contamination since
peripheral blood contain a large proportion of
naive cells.
11Sammury (2)
- Presence of HIV-1-AgSCs in breast milk from all
women, regardless plasma HIV-1 RNA levels. -
- Similar number of immunospots in aviremic vs.
viremic women. - Presence of cell-associated HIV-1 RNA in breast
milk supernatants. But, higher HIV-1 RNA levels
in supernatant of blood versus breast milk cell
culture.
12Conclusions
- HIV-1 RNA detection in breast milk from aviremic
individuals suggests a residual virus
replication. This reservoir may represent a
potential source of HIV-1 transmission via
breastfeeding from women successfully treated
with ARVs. - Alternative prevention strategies against
breastfeeding transmission of HIV-1 should be
urgently evaluated.
13Centre Muraz, Bobo-Dioulasso, Burkina
Faso Diane Valea François Rouet Nicolas
Meda
University Montpellier 1, EA 4205,Montpellier,
France Edouard Tuaillon Yassine Al
Tabaa Pierre-Alain Rubbo Vincent
Foulongne Karine Bollore Jean-Pierre Vendrell
Philippe Van de Perre
This study was supported by the Agence Nationale
de Recherches sur le Sida et les hépatites ANRS